FindTrial
Sign In

STUDY RANDOMIZED, CONTROLLED, DOUBLE BLIND, PHASE III, TO CONFRONTED LEVOBUPIVACAINA 0.2 , LEVOBUPIVACAINE 0.15 KETAMINE S 0.5 MG/KG AND LEVOBUPIVACAINA 0.125 KETAMINE S 0.5 MG/KG

STUDY RANDOMIZED, CONTROLLED, DOUBLE BLIND, PHASE III, TO CONFRONTED LEVOBUPIVACAINA 0.2 , LEVOBUPIVACAINE 0.15 KETAMINE S 0.5 MG/KG AND LEVOBUPIVACAINA 0.125 KETAMINE S 0.5 MG/KG

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-004141-18-IT
Enrollment
Unknown
Registered
2007-07-04
Start date
2004-11-23
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ANESTHESIA FOR CHILDREN SURGICAL

Interventions

Trade Name: CHIROCAINE 10F 10ML 5MG/ML PPS Pharmaceutical Form: Solution for injection INN or Proposed INN: Levobupivacaine Concentration unit: mg milligram(s) Concentration type: equal Concentration

Sponsors

AZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO A.O. DI RILIEVO NAZIONALE
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026